Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
175M
-
Number of holders
-
804
-
Total 13F shares, excl. options
-
127M
-
Shares change
-
+6.14M
-
Total reported value, excl. options
-
$21.2B
-
Value change
-
+$1B
-
Put/Call ratio
-
1.85
-
Number of buys
-
393
-
Number of sells
-
-408
-
Price
-
$166.29
Significant Holders of Teladoc Health, Inc. - Common Stock (TDOC) as of Q2 2021
1,023 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock as of Q2 2021.
Teladoc Health, Inc. - Common Stock (TDOC) has 804 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 127M shares
of 175M outstanding shares and own 72.5% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (16M shares), VANGUARD GROUP INC (12.3M shares), BlackRock Inc. (8.48M shares), BAILLIE GIFFORD & CO (8.42M shares), Sumitomo Mitsui Trust Holdings, Inc. (6.11M shares), Capital World Investors (5.71M shares), Nikko Asset Management Americas, Inc. (5.69M shares), General Catalyst Group Management, LLC (5.37M shares), MORGAN STANLEY (2.98M shares), and STATE STREET CORP (2.83M shares).
This table shows the top 804 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.